Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human monocytic leukemia expresses low levels of asparagine synthase and is potentially sensitive to L-asparaginase.

× No keyword cloud information.

5 in total

1. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

Authors: A M Aslanian; B S Fletcher; M S Kilberg
Journal: Biochem J Date: 2001-07-01 Impact factor: 3.857

2. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.

Authors: A M Aslanian; M S Kilberg
Journal: Biochem J Date: 2001-08-15 Impact factor: 3.857

3. Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells.

Authors: Yingyi He; Benshang Li; Changying Luo; Shuhong Shen; Jing Chen; Huiliang Xue; Jingyan Tang; Longjun Gu
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2011-04-20

4. A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.

Authors: Rong Liang; Guang-Xun Gao; Jie-Ping Chen; Ji-Shi Wang; Xiao-Min Wang; Yun Zeng; Qing-Xian Bai; Tao Zhang; Lan Yang; Bao-Xia Dong; Hong-Tao Gu; Mi-Mi Shu; Cai-Xia Hao; Jian-Hong Wang; Na Zhang; Xie-Qun Chen
Journal: Hematol Oncol Date: 2016-10-10 Impact factor: 5.271

5. L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma.

Authors: Weiben Yong; Wen Zheng; Yuntao Zhang; Jun Zhu; Yan Wei; Deliang Zhu; Jiyou Li
Journal: Int J Hematol Date: 2003-08 Impact factor: 2.319

5 in total